Lactated Ringer's Solution versus Hydroxyethyl Starch for Volume Replacement in Autologous Blood Donors with Cardiovascular Disease: A Controlled, Randomized Trial-Reference-Cited by-同舟云学术

Lactated Ringer's Solution versus Hydroxyethyl Starch for Volume Replacement in Autologous Blood Donors with Cardiovascular Disease: A Controlled, Randomized Trial

Published:1998-09 Issue:1 Volume:75 Page:26-31
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Kasper Stefan-Mario,Dahlmann Heinz,Mellinghoff Hermann,Ellering Jurgen,Baumann Marc,Buzello Walter

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1423-0410.1998.7510026.x/fullpdf

Reference20 articles.

1. Collection and transfusion of blood and blood components in the United States, 1992

2. Autologous transfusion: current trends and research issues. National Heart, Lung, and Blood Institute Autologous Transfusion Symposium Working Group

3. The safety of blood donation-is it what it should be?

4. Autologous Blood Procurementin the Surgical Setting:Lessons Learned in the Last 10 years

5. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Making a virtue out of an evil: Are red blood cells from chronic mountain sickness patients eligible for transfusions?;American Journal of Hematology;2024-04-15

2. Ringer’s solution;Meyler's Side Effects of Drugs;2016

3. Hydroxyethyl Starch Interferes with Human Blood Ex Vivo Coagulation, Platelet Function and Sedimentation;Acta Anaesthesiologica Taiwanica;2009-06

4. Effects of two different hydroxyethyl starch solutions (HES200/0.5 vs. HES130/0.4) on the expression of platelet membrane glycoprotein;Acta Anaesthesiologica Scandinavica;2006-10

5. A randomized crossover trial of IV fluid replacement versus no fluid replacement in autologous blood donors with cardiovascular disease;Transfusion;2002-02